Peter Nagy
Department of Molecular Biology
Max Planck Institute for Biophysical Chemistry
Göttingen
Germany
Name/email consistency: high
- Decreased accessibility and lack of activation of ErbB2 in JIMT-1, a herceptin-resistant, MUC4-expressing breast cancer cell line. Nagy, P., Friedländer, E., Tanner, M., Kapanen, A.I., Carraway, K.L., Isola, J., Jovin, T.M. Cancer Res. (2005)